APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharma and Cetirizine OTC

Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria.[1] It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria.[1] It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.

Selected research

Industry Growth & Trends

Global Pharma and Cetirizine OTC Industry Growth and Trends Forecast to 2032

21 December 2025122 pages

Choose your research edition.

Industry ResearchPharma and Cetirizine OTC Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma and Cetirizine OTC Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Pharma and Cetirizine OTC Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma and Cetirizine OTC Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma and Cetirizine OTC Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria.[1] It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.

In United States, Pharma and Cetirizine OTC key players include J & J, SANOFI-AVENTIS US LLC, PL DEVELOPMENTS INC, APOTEX, Teva, etc.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Pharma and Cetirizine OTC market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pharma and Cetirizine OTC market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharma and Cetirizine OTC market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharma and Cetirizine OTC.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pharma and Cetirizine OTC market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pharma and Cetirizine OTC Market by Company

J & J

SANOFI-AVENTIS US LLC

PL DEVELOPMENTS INC

APOTEX

Teva

MCKESSON CORP

Perrigo

Taro Pharmaceutical

CVS Pharmacy

Major® Pharmaceuticals

Mylan

Amneal

NOVARTIS

Cardinal

Jubilant Life Sciences

Novel Laboratories

Medline

Macleods

Torrent Pharmaceuticals

Micro Labs Limited

Dr. Reddy's Laboratories

Cipla

Aurobindo Pharma

Glenmark

Synthon

Magno-Humphries

Unique Pharmaceutical

ALLEGIANT HEALTH

Silarx Pharmaceuticals

Sun Pharma

UNICHEM LABORATORIES LTD

Pro Doc Limitee

NorthStar Rx LLC

ACETO

Strides Shasun

Pharma and Cetirizine OTC Segment by Type

Tablet

Capsule

Pharma and Cetirizine OTC Segment by Application

Hospital

Clinic

Drug Store

Other

Pharma and Cetirizine OTC Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma and Cetirizine OTC market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma and Cetirizine OTC and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma and Cetirizine OTC.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pharma and Cetirizine OTC manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pharma and Cetirizine OTC in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Table 2. Major Company of Capsule Table 3. Global Pharma and Cetirizine OTC Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Pharma and Cetirizine OTC Sales by Type (2021-2026) & (K Units) Table 5. Global Pharma and Cetirizine OTC Sales Market Share in Volume by Type (2021-2026) Table 6. Global Pharma and Cetirizine OTC Sales by Type (2021-2026) & (US$ Million) Table 7. Global Pharma and Cetirizine OTC Sales Market Share in Value by Type (2021-2026) Table 8. Global Pharma and Cetirizine OTC Price by Type (2021-2026) & (USD/Unit) Table 9. Global Pharma and Cetirizine OTC Sales by Type (2027-2032) & (K Units) Table 10. Global Pharma and Cetirizine OTC Sales Market Share in Volume by Type (2027-2032) Table 11. Global Pharma and Cetirizine OTC Sales by Type (2027-2032) & (US$ Million) Table 12. Global Pharma and Cetirizine OTC Sales Market Share in Value by Type (2027-2032) Table 13. Global Pharma and Cetirizine OTC Price by Type (2027-2032) & (USD/Unit) Table 14. North America Pharma and Cetirizine OTC Sales by Type (2021-2026) & (K Units) Table 15. North America Pharma and Cetirizine OTC Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Pharma and Cetirizine OTC Sales by Type (2021-2026) & (K Units) Table 17. Europe Pharma and Cetirizine OTC Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Pharma and Cetirizine OTC Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Pharma and Cetirizine OTC Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Pharma and Cetirizine OTC Sales by Type (2021-2026) & (K Units) Table 21. Latin America Pharma and Cetirizine OTC Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Pharma and Cetirizine OTC Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Pharma and Cetirizine OTC Sales by Type (2021-2026) & (US$ Million) Table 24. Pharma and Cetirizine OTC Industry Trends Table 25. Pharma and Cetirizine OTC Industry Drivers Table 26. Pharma and Cetirizine OTC Industry Opportunities and Challenges Table 27. Pharma and Cetirizine OTC Industry Restraints Table 28. Global Pharma and Cetirizine OTC Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Pharma and Cetirizine OTC Revenue Market Share by Company (2021-2026) Table 30. Global Pharma and Cetirizine OTC Sales by Company (2021-2026) & (K Units) Table 31. Global Pharma and Cetirizine OTC Sales Share by Company (2021-2026) Table 32. Global Pharma and Cetirizine OTC Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Pharma and Cetirizine OTC Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Pharma and Cetirizine OTC Major Company Production Sites and Headquarters Table 35. Global Pharma and Cetirizine OTC Company, Product Type & Application Table 36. Global Pharma and Cetirizine OTC Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Pharma and Cetirizine OTC by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Pharma and Cetirizine OTC Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Pharma and Cetirizine OTC Sales by Region (2021-2026) & (K Units) Table 41. Global Pharma and Cetirizine OTC Sales Market Share in Volume by Region (2021-2026) Table 42. Global Pharma and Cetirizine OTC Sales by Region (2021-2026) & (US$ Million) Table 43. Global Pharma and Cetirizine OTC Sales Market Share in Value by Region (2021-2026) Table 44. Global Pharma and Cetirizine OTC Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Pharma and Cetirizine OTC Sales by Region (2027-2032) & (K Units) Table 46. Global Pharma and Cetirizine OTC Sales Market Share in Volume by Region (2027-2032) Table 47. Global Pharma and Cetirizine OTC Sales by Region (2027-2032) & (US$ Million) Table 48. Global Pharma and Cetirizine OTC Sales Market Share in Value by Region (2027-2032) Table 49. Global Pharma and Cetirizine OTC Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Pharma and Cetirizine OTC Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Pharma and Cetirizine OTC Sales by Application (2021-2026) & (K Units) Table 52. Global Pharma and Cetirizine OTC Sales Market Share in Volume by Application (2021-2026) Table 53. Global Pharma and Cetirizine OTC Sales by Application (2021-2026) & (US$ Million) Table 54. Global Pharma and Cetirizine OTC Sales Market Share in Value by Application (2021-2026) Table 55. Global Pharma and Cetirizine OTC Price by Application (2021-2026) & (USD/Unit) Table 56. Global Pharma and Cetirizine OTC Sales by Application (2027-2032) & (K Units) Table 57. Global Pharma and Cetirizine OTC Sales Market Share in Volume by Application (2027-2032) Table 58. Global Pharma and Cetirizine OTC Sales by Application (2027-2032) & (US$ Million) Table 59. Global Pharma and Cetirizine OTC Sales Market Share in Value by Application (2027-2032) Table 60. Global Pharma and Cetirizine OTC Price by Application (2027-2032) & (USD/Unit) Table 61. North America Pharma and Cetirizine OTC Sales by Application (2021-2026) & (K Units) Table 62. North America Pharma and Cetirizine OTC Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Pharma and Cetirizine OTC Sales by Application (2021-2026) & (K Units) Table 64. Europe Pharma and Cetirizine OTC Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Pharma and Cetirizine OTC Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Pharma and Cetirizine OTC Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Pharma and Cetirizine OTC Sales by Application (2021-2026) & (K Units) Table 68. Latin America Pharma and Cetirizine OTC Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Pharma and Cetirizine OTC Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Pharma and Cetirizine OTC Sales by Application (2021-2026) & (US$ Million) Table 71. J & J Company Information Table 72. J & J Business Overview Table 73. J & J Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. J & J Pharma and Cetirizine OTC Product Portfolio Table 75. J & J Recent Development Table 76. SANOFI-AVENTIS US LLC Company Information Table 77. SANOFI-AVENTIS US LLC Business Overview Table 78. SANOFI-AVENTIS US LLC Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. SANOFI-AVENTIS US LLC Pharma and Cetirizine OTC Product Portfolio Table 80. SANOFI-AVENTIS US LLC Recent Development Table 81. PL DEVELOPMENTS INC Company Information Table 82. PL DEVELOPMENTS INC Business Overview Table 83. PL DEVELOPMENTS INC Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. PL DEVELOPMENTS INC Pharma and Cetirizine OTC Product Portfolio Table 85. PL DEVELOPMENTS INC Recent Development Table 86. APOTEX Company Information Table 87. APOTEX Business Overview Table 88. APOTEX Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. APOTEX Pharma and Cetirizine OTC Product Portfolio Table 90. APOTEX Recent Development Table 91. Teva Company Information Table 92. Teva Business Overview Table 93. Teva Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Teva Pharma and Cetirizine OTC Product Portfolio Table 95. Teva Recent Development Table 96. MCKESSON CORP Company Information Table 97. MCKESSON CORP Business Overview Table 98. MCKESSON CORP Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. MCKESSON CORP Pharma and Cetirizine OTC Product Portfolio Table 100. MCKESSON CORP Recent Development Table 101. Perrigo Company Information Table 102. Perrigo Business Overview Table 103. Perrigo Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Perrigo Pharma and Cetirizine OTC Product Portfolio Table 105. Perrigo Recent Development Table 106. Taro Pharmaceutical Company Information Table 107. Taro Pharmaceutical Business Overview Table 108. Taro Pharmaceutical Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Taro Pharmaceutical Pharma and Cetirizine OTC Product Portfolio Table 110. Taro Pharmaceutical Recent Development Table 111. CVS Pharmacy Company Information Table 112. CVS Pharmacy Business Overview Table 113. CVS Pharmacy Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. CVS Pharmacy Pharma and Cetirizine OTC Product Portfolio Table 115. CVS Pharmacy Recent Development Table 116. Major® Pharmaceuticals Company Information Table 117. Major® Pharmaceuticals Business Overview Table 118. Major® Pharmaceuticals Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. Major® Pharmaceuticals Pharma and Cetirizine OTC Product Portfolio Table 120. Major® Pharmaceuticals Recent Development Table 121. Mylan Company Information Table 122. Mylan Business Overview Table 123. Mylan Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Mylan Pharma and Cetirizine OTC Product Portfolio Table 125. Mylan Recent Development Table 126. Amneal Company Information Table 127. Amneal Business Overview Table 128. Amneal Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 129. Amneal Pharma and Cetirizine OTC Product Portfolio Table 130. Amneal Recent Development Table 131. NOVARTIS Company Information Table 132. NOVARTIS Business Overview Table 133. NOVARTIS Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 134. NOVARTIS Pharma and Cetirizine OTC Product Portfolio Table 135. NOVARTIS Recent Development Table 136. Cardinal Company Information Table 137. Cardinal Business Overview Table 138. Cardinal Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 139. Cardinal Pharma and Cetirizine OTC Product Portfolio Table 140. Cardinal Recent Development Table 141. Jubilant Life Sciences Company Information Table 142. Jubilant Life Sciences Business Overview Table 143. Jubilant Life Sciences Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 144. Jubilant Life Sciences Pharma and Cetirizine OTC Product Portfolio Table 145. Jubilant Life Sciences Recent Development Table 146. Novel Laboratories Company Information Table 147. Novel Laboratories Business Overview Table 148. Novel Laboratories Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 149. Novel Laboratories Pharma and Cetirizine OTC Product Portfolio Table 150. Novel Laboratories Recent Development Table 151. Medline Company Information Table 152. Medline Business Overview Table 153. Medline Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 154. Medline Pharma and Cetirizine OTC Product Portfolio Table 155. Medline Recent Development Table 156. Macleods Company Information Table 157. Macleods Business Overview Table 158. Macleods Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 159. Macleods Pharma and Cetirizine OTC Product Portfolio Table 160. Macleods Recent Development Table 161. Torrent Pharmaceuticals Company Information Table 162. Torrent Pharmaceuticals Business Overview Table 163. Torrent Pharmaceuticals Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 164. Torrent Pharmaceuticals Pharma and Cetirizine OTC Product Portfolio Table 165. Torrent Pharmaceuticals Recent Development Table 166. Micro Labs Limited Company Information Table 167. Micro Labs Limited Business Overview Table 168. Micro Labs Limited Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 169. Micro Labs Limited Pharma and Cetirizine OTC Product Portfolio Table 170. Micro Labs Limited Recent Development Table 171. Dr. Reddy's Laboratories Company Information Table 172. Dr. Reddy's Laboratories Business Overview Table 173. Dr. Reddy's Laboratories Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 174. Dr. Reddy's Laboratories Pharma and Cetirizine OTC Product Portfolio Table 175. Dr. Reddy's Laboratories Recent Development Table 176. Cipla Company Information Table 177. Cipla Business Overview Table 178. Cipla Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 179. Cipla Pharma and Cetirizine OTC Product Portfolio Table 180. Cipla Recent Development Table 181. Aurobindo Pharma Company Information Table 182. Aurobindo Pharma Business Overview Table 183. Aurobindo Pharma Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 184. Aurobindo Pharma Pharma and Cetirizine OTC Product Portfolio Table 185. Aurobindo Pharma Recent Development Table 186. Glenmark Company Information Table 187. Glenmark Business Overview Table 188. Glenmark Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 189. Glenmark Pharma and Cetirizine OTC Product Portfolio Table 190. Glenmark Recent Development Table 191. Synthon Company Information Table 192. Synthon Business Overview Table 193. Synthon Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 194. Synthon Pharma and Cetirizine OTC Product Portfolio Table 195. Synthon Recent Development Table 196. Magno-Humphries Company Information Table 197. Magno-Humphries Business Overview Table 198. Magno-Humphries Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 199. Magno-Humphries Pharma and Cetirizine OTC Product Portfolio Table 200. Magno-Humphries Recent Development Table 201. Unique Pharmaceutical Company Information Table 202. Unique Pharmaceutical Business Overview Table 203. Unique Pharmaceutical Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 204. Unique Pharmaceutical Pharma and Cetirizine OTC Product Portfolio Table 205. Unique Pharmaceutical Recent Development Table 206. ALLEGIANT HEALTH Company Information Table 207. ALLEGIANT HEALTH Business Overview Table 208. ALLEGIANT HEALTH Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 209. ALLEGIANT HEALTH Pharma and Cetirizine OTC Product Portfolio Table 210. ALLEGIANT HEALTH Recent Development Table 211. Silarx Pharmaceuticals Company Information Table 212. Silarx Pharmaceuticals Business Overview Table 213. Silarx Pharmaceuticals Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 214. Silarx Pharmaceuticals Pharma and Cetirizine OTC Product Portfolio Table 215. Silarx Pharmaceuticals Recent Development Table 216. Sun Pharma Company Information Table 217. Sun Pharma Business Overview Table 218. Sun Pharma Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 219. Sun Pharma Pharma and Cetirizine OTC Product Portfolio Table 220. Sun Pharma Recent Development Table 221. UNICHEM LABORATORIES LTD Company Information Table 222. UNICHEM LABORATORIES LTD Business Overview Table 223. UNICHEM LABORATORIES LTD Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 224. UNICHEM LABORATORIES LTD Pharma and Cetirizine OTC Product Portfolio Table 225. UNICHEM LABORATORIES LTD Recent Development Table 226. Pro Doc Limitee Company Information Table 227. Pro Doc Limitee Business Overview Table 228. Pro Doc Limitee Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 229. Pro Doc Limitee Pharma and Cetirizine OTC Product Portfolio Table 230. Pro Doc Limitee Recent Development Table 231. NorthStar Rx LLC Company Information Table 232. NorthStar Rx LLC Business Overview Table 233. NorthStar Rx LLC Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 234. NorthStar Rx LLC Pharma and Cetirizine OTC Product Portfolio Table 235. NorthStar Rx LLC Recent Development Table 236. ACETO Company Information Table 237. ACETO Business Overview Table 238. ACETO Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 239. ACETO Pharma and Cetirizine OTC Product Portfolio Table 240. ACETO Recent Development Table 241. Strides Shasun Company Information Table 242. Strides Shasun Business Overview Table 243. Strides Shasun Pharma and Cetirizine OTC Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 244. Strides Shasun Pharma and Cetirizine OTC Product Portfolio Table 245. Strides Shasun Recent Development Table 246. North America Pharma and Cetirizine OTC Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 247. North America Pharma and Cetirizine OTC Sales by Country (2021-2026) & (K Units) Table 248. North America Pharma and Cetirizine OTC Sales Market Share by Country (2021-2026) Table 249. North America Pharma and Cetirizine OTC Sales Forecast by Country (2027-2032) & (K Units) Table 250. North America Pharma and Cetirizine OTC Sales Market Share Forecast by Country (2027-2032) Table 251. North America Pharma and Cetirizine OTC Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 252. North America Pharma and Cetirizine OTC Market Size by Country (2021-2026) & (US$ Million) Table 253. North America Pharma and Cetirizine OTC Market Share by Country (2021-2026) Table 254. North America Pharma and Cetirizine OTC Market Size Forecast by Country (2027-2032) & (US$ Million) Table 255. North America Pharma and Cetirizine OTC Market Share Forecast by Country (2027-2032) Table 256. Europe Pharma and Cetirizine OTC Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 257. Europe Pharma and Cetirizine OTC Sales by Country (2021-2026) & (K Units) Table 258. Europe Pharma and Cetirizine OTC Sales Market Share by Country (2021-2026) Table 259. Europe Pharma and Cetirizine OTC Sales Forecast by Country (2027-2032) & (K Units) Table 260. Europe Pharma and Cetirizine OTC Sales Market Share Forecast by Country (2027-2032) Table 261. Europe Pharma and Cetirizine OTC Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 262. Europe Pharma and Cetirizine OTC Market Size by Country (2021-2026) & (US$ Million) Table 263. Europe Pharma and Cetirizine OTC Market Share by Country (2021-2026) Table 264. Europe Pharma and Cetirizine OTC Market Size Forecast by Country (2027-2032) & (US$ Million) Table 265. Europe Pharma and Cetirizine OTC Market Share Forecast by Country (2027-2032) Table 266. Asia-Pacific Pharma and Cetirizine OTC Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 267. Asia-Pacific Pharma and Cetirizine OTC Sales by Country (2021-2026) & (K Units) Table 268. Asia-Pacific Pharma and Cetirizine OTC Sales Market Share by Country (2021-2026) Table 269. Asia-Pacific Pharma and Cetirizine OTC Sales Forecast by Country (2027-2032) & (K Units) Table 270. Asia-Pacific Pharma and Cetirizine OTC Sales Market Share Forecast by Country (2027-2032) Table 271. Asia-Pacific Pharma and Cetirizine OTC Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 272. Asia-Pacific Pharma and Cetirizine OTC Market Size by Country (2021-2026) & (US$ Million) Table 273. Asia-Pacific Pharma and Cetirizine OTC Market Share by Country (2021-2026) Table 274. Asia-Pacific Pharma and Cetirizine OTC Market Size Forecast by Country (2027-2032) & (US$ Million) Table 275. Asia-Pacific Pharma and Cetirizine OTC Market Share Forecast by Country (2027-2032) Table 276. Latin America Pharma and Cetirizine OTC Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 277. Latin America Pharma and Cetirizine OTC Sales by Country (2021-2026) & (K Units) Table 278. Latin America Pharma and Cetirizine OTC Sales Market Share by Country (2021-2026) Table 279. Latin America Pharma and Cetirizine OTC Sales Forecast by Country (2027-2032) & (K Units) Table 280. Latin America Pharma and Cetirizine OTC Sales Market Share Forecast by Country (2027-2032) Table 281. Latin America Pharma and Cetirizine OTC Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 282. Latin America Pharma and Cetirizine OTC Market Size by Country (2021-2026) & (US$ Million) Table 283. Latin America Pharma and Cetirizine OTC Market Share by Country (2021-2026) Table 284. Latin America Pharma and Cetirizine OTC Market Size Forecast by Country (2027-2032) & (US$ Million) Table 285. Latin America Pharma and Cetirizine OTC Market Share Forecast by Country (2027-2032) Table 286. Middle East and Africa Pharma and Cetirizine OTC Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 287. Middle East and Africa Pharma and Cetirizine OTC Sales by Country (2021-2026) & (K Units) Table 288. Middle East and Africa Pharma and Cetirizine OTC Sales Market Share by Country (2021-2026) Table 289. Middle East and Africa Pharma and Cetirizine OTC Sales Forecast by Country (2027-2032) & (K Units) Table 290. Middle East and Africa Pharma and Cetirizine OTC Sales Market Share Forecast by Country (2027-2032) Table 291. Middle East and Africa Pharma and Cetirizine OTC Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 292. Middle East and Africa Pharma and Cetirizine OTC Market Size by Country (2021-2026) & (US$ Million) Table 293. Middle East and Africa Pharma and Cetirizine OTC Market Share by Country (2021-2026) Table 294. Middle East and Africa Pharma and Cetirizine OTC Market Size Forecast by Country (2027-2032) & (US$ Million) Table 295. Middle East and Africa Pharma and Cetirizine OTC Market Share Forecast by Country (2027-2032) Table 296. Key Raw Materials Table 297. Raw Materials Key Suppliers Table 298. Pharma and Cetirizine OTC Distributors List Table 299. Pharma and Cetirizine OTC Customers List Table 300. Research Programs/Design for This Report Table 301. Authors List of This Report Table 302. Secondary Sources Table 303. Primary Sources List of Figures Figure 1. Pharma and Cetirizine OTC Image Figure 2. Global Pharma and Cetirizine OTC Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharma and Cetirizine OTC Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharma and Cetirizine OTC Sales (2021-2032) & (K Units) Figure 5. Tablet Image Figure 6. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. Capsule Image Figure 8. Global Capsule Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Pharma and Cetirizine OTC Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Pharma and Cetirizine OTC Market Share by Type 2025 VS 2032 Figure 11. North America Pharma and Cetirizine OTC Sales Market Share in Volume by Type in 2025 Figure 12. North America Pharma and Cetirizine OTC Sales Market Share in Value by Type in 2025 Figure 13. Europe Pharma and Cetirizine OTC Sales Market Share in Volume by Type in 2025 Figure 14. Europe Pharma and Cetirizine OTC Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Pharma and Cetirizine OTC Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Pharma and Cetirizine OTC Sales Market Share in Value by Type in 2025 Figure 17. Latin America Pharma and Cetirizine OTC Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Pharma and Cetirizine OTC Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Pharma and Cetirizine OTC Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Pharma and Cetirizine OTC Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Pharma and Cetirizine OTC Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Drug Store Image Figure 28. Global Drug Store Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Pharma and Cetirizine OTC Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Pharma and Cetirizine OTC Market Share by Application 2025 VS 2032 Figure 33. North America Pharma and Cetirizine OTC Sales Market Share in Volume by Application in 2025 Figure 34. North America Pharma and Cetirizine OTC Sales Market Share in Value by Application in 2025 Figure 35. Europe Pharma and Cetirizine OTC Sales Market Share in Volume by Application in 2025 Figure 36. Europe Pharma and Cetirizine OTC Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Pharma and Cetirizine OTC Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Pharma and Cetirizine OTC Sales Market Share in Value by Application in 2025 Figure 39. Latin America Pharma and Cetirizine OTC Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Pharma and Cetirizine OTC Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Pharma and Cetirizine OTC Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Pharma and Cetirizine OTC Sales Market Share in Value by Application in 2025 Figure 43. North America Pharma and Cetirizine OTC Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Pharma and Cetirizine OTC Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Pharma and Cetirizine OTC Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Pharma and Cetirizine OTC Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pharma and Cetirizine OTC Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Pharma and Cetirizine OTC Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pharma and Cetirizine OTC Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Pharma and Cetirizine OTC Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pharma and Cetirizine OTC Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Pharma and Cetirizine OTC Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pharma and Cetirizine OTC Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Pharma and Cetirizine OTC Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pharma and Cetirizine OTC Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Pharma and Cetirizine OTC Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pharma and Cetirizine OTC Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Pharma and Cetirizine OTC Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pharma and Cetirizine OTC Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Pharma and Cetirizine OTC Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pharma and Cetirizine OTC Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Pharma and Cetirizine OTC Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Pharma and Cetirizine OTC Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Pharma and Cetirizine OTC Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
Applications
  • Hospital
  • Clinic
  • Drug Store
  • Other
Companies covered
  • J & J
  • SANOFI-AVENTIS US LLC
  • PL DEVELOPMENTS INC
  • APOTEX
  • Teva
  • MCKESSON CORP
  • Perrigo
  • Taro Pharmaceutical
  • CVS Pharmacy
  • Major® Pharmaceuticals
  • Mylan
  • Amneal
  • NOVARTIS
  • Cardinal
  • Jubilant Life Sciences
  • Novel Laboratories
  • Medline
  • Macleods
  • Torrent Pharmaceuticals
  • Micro Labs Limited
  • Dr. Reddy's Laboratories
  • Cipla
  • Aurobindo Pharma
  • Glenmark
  • Synthon
  • Magno-Humphries
  • Unique Pharmaceutical
  • ALLEGIANT HEALTH
  • Silarx Pharmaceuticals
  • Sun Pharma
  • UNICHEM LABORATORIES LTD
  • Pro Doc Limitee
  • NorthStar Rx LLC
  • ACETO
  • Strides Shasun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharma and Cetirizine OTC Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pharma and Cetirizine OTC Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pharma and Cetirizine OTC Market by Type
  6. 1.3.1 Tablet
  7. 1.3.2 Capsule
  8. 1.4 Global Pharma and Cetirizine OTC Market Size by Type
  9. 1.4.1 Global Pharma and Cetirizine OTC Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Pharma and Cetirizine OTC Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Pharma and Cetirizine OTC Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Pharma and Cetirizine OTC Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Pharma and Cetirizine OTC Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Pharma and Cetirizine OTC Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Pharma and Cetirizine OTC Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Pharma and Cetirizine OTC Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pharma and Cetirizine OTC Industry Trends
  2. 2.2 Pharma and Cetirizine OTC Industry Drivers
  3. 2.3 Pharma and Cetirizine OTC Industry Opportunities and Challenges
  4. 2.4 Pharma and Cetirizine OTC Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pharma and Cetirizine OTC Revenue (2021-2026)
  2. 3.2 Global Top Players by Pharma and Cetirizine OTC Sales (2021-2026)
  3. 3.3 Global Top Players by Pharma and Cetirizine OTC Price (2021-2026)
  4. 3.4 Global Pharma and Cetirizine OTC Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharma and Cetirizine OTC Major Company Production Sites & Headquarters
  6. 3.6 Global Pharma and Cetirizine OTC Company, Product Type & Application
  7. 3.7 Global Pharma and Cetirizine OTC Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pharma and Cetirizine OTC Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pharma and Cetirizine OTC Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pharma and Cetirizine OTC Tier 1, Tier 2, and Tier 3
4 Pharma and Cetirizine OTC Regional Status and Outlook
  1. 4.1 Global Pharma and Cetirizine OTC Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pharma and Cetirizine OTC Historic Market Size by Region
  3. 4.2.1 Global Pharma and Cetirizine OTC Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pharma and Cetirizine OTC Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pharma and Cetirizine OTC Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pharma and Cetirizine OTC Forecasted Market Size by Region
  7. 4.3.1 Global Pharma and Cetirizine OTC Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pharma and Cetirizine OTC Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pharma and Cetirizine OTC Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pharma and Cetirizine OTC by Application
  1. 5.1 Pharma and Cetirizine OTC Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Drug Store
  5. 5.1.4 Other
  6. 5.2 Global Pharma and Cetirizine OTC Market Size by Application
  7. 5.2.1 Global Pharma and Cetirizine OTC Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Pharma and Cetirizine OTC Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Pharma and Cetirizine OTC Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Pharma and Cetirizine OTC Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Pharma and Cetirizine OTC Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Pharma and Cetirizine OTC Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Pharma and Cetirizine OTC Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Pharma and Cetirizine OTC Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 J & J
  2. 6.1.1 J & J Company Information
  3. 6.1.2 J & J Business Overview
  4. 6.1.3 J & J Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 J & J Pharma and Cetirizine OTC Product Portfolio
  6. 6.1.5 J & J Recent Developments
  7. 6.2 SANOFI-AVENTIS US LLC
  8. 6.2.1 SANOFI-AVENTIS US LLC Company Information
  9. 6.2.2 SANOFI-AVENTIS US LLC Business Overview
  10. 6.2.3 SANOFI-AVENTIS US LLC Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 SANOFI-AVENTIS US LLC Pharma and Cetirizine OTC Product Portfolio
  12. 6.2.5 SANOFI-AVENTIS US LLC Recent Developments
  13. 6.3 PL DEVELOPMENTS INC
  14. 6.3.1 PL DEVELOPMENTS INC Company Information
  15. 6.3.2 PL DEVELOPMENTS INC Business Overview
  16. 6.3.3 PL DEVELOPMENTS INC Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 PL DEVELOPMENTS INC Pharma and Cetirizine OTC Product Portfolio
  18. 6.3.5 PL DEVELOPMENTS INC Recent Developments
  19. 6.4 APOTEX
  20. 6.4.1 APOTEX Company Information
  21. 6.4.2 APOTEX Business Overview
  22. 6.4.3 APOTEX Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 APOTEX Pharma and Cetirizine OTC Product Portfolio
  24. 6.4.5 APOTEX Recent Developments
  25. 6.5 Teva
  26. 6.5.1 Teva Company Information
  27. 6.5.2 Teva Business Overview
  28. 6.5.3 Teva Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Teva Pharma and Cetirizine OTC Product Portfolio
  30. 6.5.5 Teva Recent Developments
  31. 6.6 MCKESSON CORP
  32. 6.6.1 MCKESSON CORP Company Information
  33. 6.6.2 MCKESSON CORP Business Overview
  34. 6.6.3 MCKESSON CORP Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 MCKESSON CORP Pharma and Cetirizine OTC Product Portfolio
  36. 6.6.5 MCKESSON CORP Recent Developments
  37. 6.7 Perrigo
  38. 6.7.1 Perrigo Company Information
  39. 6.7.2 Perrigo Business Overview
  40. 6.7.3 Perrigo Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Perrigo Pharma and Cetirizine OTC Product Portfolio
  42. 6.7.5 Perrigo Recent Developments
  43. 6.8 Taro Pharmaceutical
  44. 6.8.1 Taro Pharmaceutical Company Information
  45. 6.8.2 Taro Pharmaceutical Business Overview
  46. 6.8.3 Taro Pharmaceutical Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Taro Pharmaceutical Pharma and Cetirizine OTC Product Portfolio
  48. 6.8.5 Taro Pharmaceutical Recent Developments
  49. 6.9 CVS Pharmacy
  50. 6.9.1 CVS Pharmacy Company Information
  51. 6.9.2 CVS Pharmacy Business Overview
  52. 6.9.3 CVS Pharmacy Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 CVS Pharmacy Pharma and Cetirizine OTC Product Portfolio
  54. 6.9.5 CVS Pharmacy Recent Developments
  55. 6.10 Major® Pharmaceuticals
  56. 6.10.1 Major® Pharmaceuticals Company Information
  57. 6.10.2 Major® Pharmaceuticals Business Overview
  58. 6.10.3 Major® Pharmaceuticals Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Major® Pharmaceuticals Pharma and Cetirizine OTC Product Portfolio
  60. 6.10.5 Major® Pharmaceuticals Recent Developments
  61. 6.11 Mylan
  62. 6.11.1 Mylan Company Information
  63. 6.11.2 Mylan Business Overview
  64. 6.11.3 Mylan Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Mylan Pharma and Cetirizine OTC Product Portfolio
  66. 6.11.5 Mylan Recent Developments
  67. 6.12 Amneal
  68. 6.12.1 Amneal Company Information
  69. 6.12.2 Amneal Business Overview
  70. 6.12.3 Amneal Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Amneal Pharma and Cetirizine OTC Product Portfolio
  72. 6.12.5 Amneal Recent Developments
  73. 6.13 NOVARTIS
  74. 6.13.1 NOVARTIS Company Information
  75. 6.13.2 NOVARTIS Business Overview
  76. 6.13.3 NOVARTIS Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 NOVARTIS Pharma and Cetirizine OTC Product Portfolio
  78. 6.13.5 NOVARTIS Recent Developments
  79. 6.14 Cardinal
  80. 6.14.1 Cardinal Company Information
  81. 6.14.2 Cardinal Business Overview
  82. 6.14.3 Cardinal Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Cardinal Pharma and Cetirizine OTC Product Portfolio
  84. 6.14.5 Cardinal Recent Developments
  85. 6.15 Jubilant Life Sciences
  86. 6.15.1 Jubilant Life Sciences Company Information
  87. 6.15.2 Jubilant Life Sciences Business Overview
  88. 6.15.3 Jubilant Life Sciences Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Jubilant Life Sciences Pharma and Cetirizine OTC Product Portfolio
  90. 6.15.5 Jubilant Life Sciences Recent Developments
  91. 6.16 Novel Laboratories
  92. 6.16.1 Novel Laboratories Company Information
  93. 6.16.2 Novel Laboratories Business Overview
  94. 6.16.3 Novel Laboratories Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Novel Laboratories Pharma and Cetirizine OTC Product Portfolio
  96. 6.16.5 Novel Laboratories Recent Developments
  97. 6.17 Medline
  98. 6.17.1 Medline Company Information
  99. 6.17.2 Medline Business Overview
  100. 6.17.3 Medline Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Medline Pharma and Cetirizine OTC Product Portfolio
  102. 6.17.5 Medline Recent Developments
  103. 6.18 Macleods
  104. 6.18.1 Macleods Company Information
  105. 6.18.2 Macleods Business Overview
  106. 6.18.3 Macleods Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Macleods Pharma and Cetirizine OTC Product Portfolio
  108. 6.18.5 Macleods Recent Developments
  109. 6.19 Torrent Pharmaceuticals
  110. 6.19.1 Torrent Pharmaceuticals Company Information
  111. 6.19.2 Torrent Pharmaceuticals Business Overview
  112. 6.19.3 Torrent Pharmaceuticals Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Torrent Pharmaceuticals Pharma and Cetirizine OTC Product Portfolio
  114. 6.19.5 Torrent Pharmaceuticals Recent Developments
  115. 6.20 Micro Labs Limited
  116. 6.20.1 Micro Labs Limited Company Information
  117. 6.20.2 Micro Labs Limited Business Overview
  118. 6.20.3 Micro Labs Limited Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Micro Labs Limited Pharma and Cetirizine OTC Product Portfolio
  120. 6.20.5 Micro Labs Limited Recent Developments
  121. 6.21 Dr. Reddy's Laboratories
  122. 6.21.1 Dr. Reddy's Laboratories Company Information
  123. 6.21.2 Dr. Reddy's Laboratories Business Overview
  124. 6.21.3 Dr. Reddy's Laboratories Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Dr. Reddy's Laboratories Pharma and Cetirizine OTC Product Portfolio
  126. 6.21.5 Dr. Reddy's Laboratories Recent Developments
  127. 6.22 Cipla
  128. 6.22.1 Cipla Company Information
  129. 6.22.2 Cipla Business Overview
  130. 6.22.3 Cipla Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Cipla Pharma and Cetirizine OTC Product Portfolio
  132. 6.22.5 Cipla Recent Developments
  133. 6.23 Aurobindo Pharma
  134. 6.23.1 Aurobindo Pharma Company Information
  135. 6.23.2 Aurobindo Pharma Business Overview
  136. 6.23.3 Aurobindo Pharma Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Aurobindo Pharma Pharma and Cetirizine OTC Product Portfolio
  138. 6.23.5 Aurobindo Pharma Recent Developments
  139. 6.24 Glenmark
  140. 6.24.1 Glenmark Company Information
  141. 6.24.2 Glenmark Business Overview
  142. 6.24.3 Glenmark Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Glenmark Pharma and Cetirizine OTC Product Portfolio
  144. 6.24.5 Glenmark Recent Developments
  145. 6.25 Synthon
  146. 6.25.1 Synthon Company Information
  147. 6.25.2 Synthon Business Overview
  148. 6.25.3 Synthon Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Synthon Pharma and Cetirizine OTC Product Portfolio
  150. 6.25.5 Synthon Recent Developments
  151. 6.26 Magno-Humphries
  152. 6.26.1 Magno-Humphries Company Information
  153. 6.26.2 Magno-Humphries Business Overview
  154. 6.26.3 Magno-Humphries Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 Magno-Humphries Pharma and Cetirizine OTC Product Portfolio
  156. 6.26.5 Magno-Humphries Recent Developments
  157. 6.27 Unique Pharmaceutical
  158. 6.27.1 Unique Pharmaceutical Company Information
  159. 6.27.2 Unique Pharmaceutical Business Overview
  160. 6.27.3 Unique Pharmaceutical Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  161. 6.27.4 Unique Pharmaceutical Pharma and Cetirizine OTC Product Portfolio
  162. 6.27.5 Unique Pharmaceutical Recent Developments
  163. 6.28 ALLEGIANT HEALTH
  164. 6.28.1 ALLEGIANT HEALTH Company Information
  165. 6.28.2 ALLEGIANT HEALTH Business Overview
  166. 6.28.3 ALLEGIANT HEALTH Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  167. 6.28.4 ALLEGIANT HEALTH Pharma and Cetirizine OTC Product Portfolio
  168. 6.28.5 ALLEGIANT HEALTH Recent Developments
  169. 6.29 Silarx Pharmaceuticals
  170. 6.29.1 Silarx Pharmaceuticals Company Information
  171. 6.29.2 Silarx Pharmaceuticals Business Overview
  172. 6.29.3 Silarx Pharmaceuticals Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  173. 6.29.4 Silarx Pharmaceuticals Pharma and Cetirizine OTC Product Portfolio
  174. 6.29.5 Silarx Pharmaceuticals Recent Developments
  175. 6.30 Sun Pharma
  176. 6.30.1 Sun Pharma Company Information
  177. 6.30.2 Sun Pharma Business Overview
  178. 6.30.3 Sun Pharma Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  179. 6.30.4 Sun Pharma Pharma and Cetirizine OTC Product Portfolio
  180. 6.30.5 Sun Pharma Recent Developments
  181. 6.31 UNICHEM LABORATORIES LTD
  182. 6.31.1 UNICHEM LABORATORIES LTD Company Information
  183. 6.31.2 UNICHEM LABORATORIES LTD Business Overview
  184. 6.31.3 UNICHEM LABORATORIES LTD Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  185. 6.31.4 UNICHEM LABORATORIES LTD Pharma and Cetirizine OTC Product Portfolio
  186. 6.31.5 UNICHEM LABORATORIES LTD Recent Developments
  187. 6.32 Pro Doc Limitee
  188. 6.32.1 Pro Doc Limitee Company Information
  189. 6.32.2 Pro Doc Limitee Business Overview
  190. 6.32.3 Pro Doc Limitee Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  191. 6.32.4 Pro Doc Limitee Pharma and Cetirizine OTC Product Portfolio
  192. 6.32.5 Pro Doc Limitee Recent Developments
  193. 6.33 NorthStar Rx LLC
  194. 6.33.1 NorthStar Rx LLC Company Information
  195. 6.33.2 NorthStar Rx LLC Business Overview
  196. 6.33.3 NorthStar Rx LLC Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  197. 6.33.4 NorthStar Rx LLC Pharma and Cetirizine OTC Product Portfolio
  198. 6.33.5 NorthStar Rx LLC Recent Developments
  199. 6.34 ACETO
  200. 6.34.1 ACETO Company Information
  201. 6.34.2 ACETO Business Overview
  202. 6.34.3 ACETO Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  203. 6.34.4 ACETO Pharma and Cetirizine OTC Product Portfolio
  204. 6.34.5 ACETO Recent Developments
  205. 6.35 Strides Shasun
  206. 6.35.1 Strides Shasun Company Information
  207. 6.35.2 Strides Shasun Business Overview
  208. 6.35.3 Strides Shasun Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2021-2026)
  209. 6.35.4 Strides Shasun Pharma and Cetirizine OTC Product Portfolio
  210. 6.35.5 Strides Shasun Recent Developments
7 North America by Country
  1. 7.1 North America Pharma and Cetirizine OTC Sales by Country
  2. 7.1.1 North America Pharma and Cetirizine OTC Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pharma and Cetirizine OTC Sales by Country (2021-2026)
  4. 7.1.3 North America Pharma and Cetirizine OTC Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pharma and Cetirizine OTC Market Size by Country
  6. 7.2.1 North America Pharma and Cetirizine OTC Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pharma and Cetirizine OTC Market Size by Country (2021-2026)
  8. 7.2.3 North America Pharma and Cetirizine OTC Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pharma and Cetirizine OTC Sales by Country
  2. 8.1.1 Europe Pharma and Cetirizine OTC Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pharma and Cetirizine OTC Sales by Country (2021-2026)
  4. 8.1.3 Europe Pharma and Cetirizine OTC Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pharma and Cetirizine OTC Market Size by Country
  6. 8.2.1 Europe Pharma and Cetirizine OTC Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pharma and Cetirizine OTC Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pharma and Cetirizine OTC Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pharma and Cetirizine OTC Sales by Country
  2. 9.1.1 Asia-Pacific Pharma and Cetirizine OTC Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pharma and Cetirizine OTC Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pharma and Cetirizine OTC Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pharma and Cetirizine OTC Market Size by Country
  6. 9.2.1 Asia-Pacific Pharma and Cetirizine OTC Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pharma and Cetirizine OTC Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pharma and Cetirizine OTC Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pharma and Cetirizine OTC Sales by Country
  2. 10.1.1 South America Pharma and Cetirizine OTC Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pharma and Cetirizine OTC Sales by Country (2021-2026)
  4. 10.1.3 South America Pharma and Cetirizine OTC Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pharma and Cetirizine OTC Market Size by Country
  6. 10.2.1 South America Pharma and Cetirizine OTC Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pharma and Cetirizine OTC Market Size by Country (2021-2026)
  8. 10.2.3 South America Pharma and Cetirizine OTC Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pharma and Cetirizine OTC Sales by Country
  2. 11.1.1 Middle East and Africa Pharma and Cetirizine OTC Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pharma and Cetirizine OTC Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pharma and Cetirizine OTC Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pharma and Cetirizine OTC Market Size by Country
  6. 11.2.1 Middle East and Africa Pharma and Cetirizine OTC Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pharma and Cetirizine OTC Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pharma and Cetirizine OTC Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pharma and Cetirizine OTC Value Chain Analysis
  2. 12.1.1 Pharma and Cetirizine OTC Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pharma and Cetirizine OTC Production Mode & Process
  7. 12.2 Pharma and Cetirizine OTC Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pharma and Cetirizine OTC Distributors
  10. 12.2.3 Pharma and Cetirizine OTC Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst